Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma

NCT00144976 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Neoplasms

Interventions

DRUG: Tarceva

Sponsor

Institut Claudius Regaud

Collaborators

[object Object]